510(k) Report

FDA applicant

Tianjin Huahong Technology Co., Ltd.

Tianjin, CN16 decisions2021–20260 recalls

FDA records 16 decisions for Tianjin Huahong Technology Co., Ltd. (Tianjin, CN) from 2021 to 2026: 16 510(k) clearances. Most are in product codes FMK (Single Use Only Blood Lancet With An Integral…) and QRL (Multiple Use Blood Lancet For Single Patient…). Since 2016 its 510(k)s took a median of 67 days from receipt to decision, against 68 for FDA’s reviews in the same codes and years. Its devices cite 18 predicates, 10 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general and plastic surgery panel, where it files most

How often FDA has decided Tianjin Huahong Technology Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2025

2021: 12022: 42024: 32025: 22026 (partial year): 6
2021high 6 (2026) · low 0 (2023)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2021.

FIG. 1 — Tianjin Huahong Technology Co., Ltd. by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Tianjin Huahong Technology Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report